At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 1
- ✓Diagnosis of Sézary syndrome according to WHO-EORTC classification
Key exclusion· 3
- ✕Pregnant patients
- ✕Severe anemia (hemoglobin <7.5 mg/dL)
- ✕Unable to provide informed consent
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Searching for Oncogenic Viruses in Sézary Cells Using a Novel Viral Discovery Technique, VirCapSeq-VERT
In Brief
An observational study for Lymphoma, T-Cell, Cutaneous and Sézary Syndrome. Completed, enrolled 6 participants across 1 site.
Detailed Summary
This study will be using this technique, called "VirCapSeq-VERT" to analyze the white blood cells of patients with Sézary syndrome. This could provide the foundation for future studies looking to understand the role that viruses play in the origin of Sézary syndrome. This could have important implications for the future development of new and effective therapies for the disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLymphoma, T-Cell, Cutaneous, Sézary Syndrome
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
First PostedJul 2016
Primary CompletionOct 2016
TodayJul 2026
First PostedJul 19, 2016
Enrollment StartJun 1, 2016
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.0 years ago